Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
about
Adipocytokines in renal transplant recipientsAdipokines as a link between obesity and chronic kidney diseaseThe role of mammalian sirtuins in the regulation of metabolism, aging, and longevityRegulation of cell survival and death by pyridine nucleotidesEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsStudy of Visfatin Level in Type 1 Diabetic Children and AdolescentsVisfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.The function of nicotinamide phosphoribosyltransferase in the heart.The role of visfatin in diabetic nephropathyPathophysiological role and therapeutic implications of inflammation in diabetic nephropathySirtuins and their relevance to the kidney.Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.Association between serum visfatin and carotid atherosclerosis in diabetic and non-diabetic patients on maintenance hemodialysisIncreased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.Visfatin/Nampt: an adipokine with cardiovascular impactPre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions.Adipokines protecting CKD.Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.Nampt: linking NAD biology, metabolism and cancer.High-Intensity Exercise and Carbohydrate Supplementation do not Alter Plasma Visfatin.Adipokines promote chronic kidney disease.Physiological and pathophysiological roles of NAMPT and NAD metabolism.Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells.Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.Neuronal protective role of PBEF in a mouse model of cerebral ischemiaVisfatin is involved in TNFα-mediated insulin resistance via an NAD(+)/Sirt1/PTP1B pathway in 3T3-L1 adipocytes.Endogenous Nampt upregulation is associated with diabetic nephropathy inflammatory-fibrosis through the NF-κB p65 and Sirt1 pathway; NMN alleviates diabetic nephropathy inflammatory-fibrosis by inhibiting endogenous Nampt.Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy.CNS Targets of Adipokines.Obesity and kidney disease: Beyond the hyperfiltration.The association between plasma visfatin levels and ED.
P2860
Q26747604-1508E033-3798-41F0-A5BC-615E3CD49CEBQ26825339-C772FDE6-173A-49A3-AAA4-D8AF15F85AB9Q26865526-99B7EA0A-0093-49BD-9765-25E0D51EF0E9Q27026075-E434AD58-77C4-4359-BBAA-140E28259161Q28730724-4CF449B6-2FAF-4538-9C57-4533F0416F3BQ33889578-5F3A6CF3-5799-4F30-9FC8-5846B136978EQ34235479-D168D43D-6E9F-438B-9FAC-3A6B3BF3B265Q34623236-BC8616EE-EADE-428D-8DD9-9696D849D6F1Q35656272-432C4DCC-7F05-45B9-A9AE-BB6BD7086A2FQ35673446-1207629A-1A37-4271-8B26-E79C45BEFE0AQ35923139-95D732B4-5A98-4753-A87B-2D2C1FE0A69AQ36014103-6495BAFE-6471-4BD1-834E-7DF22B29CBB7Q36766658-5980DEA4-048D-4113-9879-26F2022F73FDQ36950161-12E70E6E-90F3-4A0E-B5D8-662D2F6EF4A6Q36970010-057E2645-A916-4265-9817-704462858FF6Q37216851-283FB966-FA41-4F02-98F2-CC27271DEAECQ37270838-1A7CDC13-DDBF-417C-9838-F92BCCBE8E31Q37324960-1B5C84A9-31DF-4F21-95E3-0720B5E1A422Q37334248-5CFAE463-8891-4BDC-8455-F39F07C49205Q37711085-73B6D80F-0023-45C9-8425-5A23DF0C45F9Q38157808-312B87D7-6613-431C-9487-299D1BA9A2CBQ38555243-DF0BCAF4-5C90-4B9D-8CE6-4EB8435E5903Q38927815-37ECA3CF-BAA2-481B-828D-7A30E0EC23D3Q39593990-C7B67148-8030-42A9-85DC-54BCB92018A0Q41185582-9D30D394-2F10-4E89-B13F-BC3DC88836B6Q42747622-601605FD-B64A-49C7-B812-D6857FE207A2Q45747480-0A7C6BBD-F1EF-473C-B3D0-C94BC8DDF4CFQ46014820-AEF4518B-47E8-4737-9026-D22C3EF4B99BQ47978333-EB1C9ABA-04F8-4A4F-A8B7-9A245D567A2DQ50318280-213E9685-6A68-4197-8BEC-4CC89AC93654Q51307688-7506AEDC-E843-42D4-AC22-A44A17136ED0
P2860
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
description
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im November 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/11/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/11/01)
@nl
наукова стаття, опублікована в листопаді 2008
@uk
مقالة علمية (نشرت في نوفمبر 2008)
@ar
name
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@ast
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@en
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@nl
type
label
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@ast
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@en
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@nl
prefLabel
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@ast
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@en
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@nl
P2093
P2860
P1476
Visfatin: a new player in mesangial cell physiology and diabetic nephropathy
@en
P2093
Bo Kyung Kim
Dae Ryong Cha
Gang Jee Ko
Hye Kyoung Song
Hyoung Kyu Kim
Jee Young Han
Kum Hyun Han
Mi Hwa Lee
Sang Youb Han
Young Sun Kang
P2860
P304
F1485–1494
P356
10.1152/AJPRENAL.90231.2008
P577
2008-11-01T00:00:00Z